Angrist, B. & Sudilorsky, A. (1978) Central nervous system stimulants.
Handbook of Psychopharmacology, Vol. II: Stimulants (
Iversen, L. L.
Iversen, S. D. and Snyder, S. H.). Pp 111–165. New York, London: Plenum Press.
Angrist, B. & Gershon, S. (1980) The phenomenology of experimentally-induced amphetamine psychosis—preliminary observation. Biological Psychiatry, 2, 95–107.
Bertler, A. (1961) Occurrence and localization of catecholamines in the human brain. Acta Physiologica Scandinavica, 51, 97–107.
Checkley, S. A. (1978) A new distinction between the euphoric and the antidepressant effects of methlyamphetamine. British Journal of Psychiatry, 133, 416–423.
Dixon, W. J. & Brown, M. B. () (1977) Biomedical Computer Programs P-Series. Berkeley: University of California Press.
Estler, C. J. (1975) Effect of amphetamine-type psychostimulants on brain metabolism. Advances in Pharmacology and Chemistry, 13, 305–357.
Gunne, L. M.
Anggard, E. & Jonsson, L. W. (1972) Clinical trials with amphetamine blocking drugs. Psychiatry, Neurology, Neurochemistry (Amst.), 75, 225–226.
Asnis, G. M.
Tabrizi, M. A. & Sachar, E. J. (1980) Diurnal growth hormone responses to dextroamphetamine in normal young men and postmenopausal women. Psychoneuroendocrinology, 5, 339–344.
Janowski, D. S.
El-Yussef, M. D.
Davis, M. M. & Sekerke, H. J. (1973) Provocation of schizophrenic symptoms by intravenous administration of methylphenidate. Archives of General Psychiatry, 28, 185–191.
Janowski, D. S. & Davis, J. B. (1974) Dopamine psychomotor stimulants and schizophrenia: Effects of methylphenidate and the sterioisomers of amphetamines in schizophrenics.
Neuropsychopharmacology of Monoamines and Their Regulatory Enzymes (
Usdin, E.). Pp 317–323. New York: Raven Press.
Janowski, D. S. & Davis, J. B. (1976) Methylphenidate, dextroamphetamine levamphetamine effects on schizophrenic symptoms. Archives of General Psychiatry, 33, 304–308.
Jonsson, L. W. (1972) Pharmacological blockade of amphetamine effects in amphetamine dependent subjects. European Journal of Clinical Pharmacology, 4, 206–211.
Jonsson, L. W.
Gunne, L. M. & Anggard, E. (1969) Effects of alphamethyltyrosine in amphetamine dependent subject
Pharmacologica Clinica, 2, 27–29.
Kleiber, E. L.
Broverman, D. M. & Hall, F. (1971) Plasma MAO activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and progestin. Journal of Clinical Endocrinology, 33, 630–637.
von Felsinger, J. M. & Beecher, H. K. (1955) Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and ‘post-addicts's. Journal of the American Medical Association, 157, 1006–1020.
McGeer, E. & McGeer, P. L. (1976) Neurotransmitter metabolism in the aging brain.
Neurobiology of Aging (
Terry, R. D. and Gerhson, S.). Pp 389–403. New York: Raven Press.
Martin, W. R.
Sloan, J. W.
Sapira, J. D. & Jasinski, D. R. (1971) Physiological, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245–258.
Moore, R. E. (1978) Amphetamines: Biochemical and behavioral actions in animals.
Handbook of Psychopharmacology, Vol. II: Stimulants, (
Iversen, L. L.
Iversen, S. D. and Snyder, S. H.). Pp 41–98. New York, London: Plenum Press.
Nicholson, A. N. (1978) Visual analogue scales and drug effects in man. British Journal of Clinical Pharmacology, 6, 3–4.
Reifenstein, F. C. Jr. & Davidoff, E. (1939) Benzedrine sulfate therapy, the present status. New York State Journal of Medicine, 1939, 42–57.
Robinson, D. S. (1975) Changes in monoamine oxidase and monoamines with human development and aging. Federal Proceedings, 34, 103–107.
Von Felsinger, J. M.
Lasagna, L. & Beecher, H. K. (1955) Drug-induced mood changes in man. 2. Personality and reaction to drugs. Journal of the American Medical Association, 157, 1113–1119.